Budesonide is a glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis. Among its listed roles, it functions as a anti-inflammatory drug, a bronchodilator agent and a drug allergen. It is an 11beta-hydroxy steroid, a glucocorticoid, a cyclic acetal, a 20-oxo steroid, a 21-hydroxy steroid, a 3-oxo-Delta(1),Delta(4)-steroid and a primary alpha-hydroxy ketone. It is derived from a hydride of a pregnane. It is grouped under the following drug class(es): Corticosteroids, Ophthalmic corticosteroids and Steroids. Its therapeutic use is listed as anti-asthmatic agents, anti-inflammatories, dermatologicals and gastrointestinal agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Preferid, Entocort and Rhinocort. Its PubChem CID is 5281004.
Budesonide
| CAS No | 51333-22-3 |
|---|---|
| Molecular Formula | C25H34O6 |
| Molecular Weight | 430.5 g/mol |
| Synonyms | (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Budesonide is a glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis.
The listed CAS number is 51333-22-3.
The listed molecular formula is C25H34O6.
The listed molecular weight is 430.5 g/mol.
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one.
The source lists Preferid, Entocort and Rhinocort.